The hybrid workplace is here, and by most accounts, biopharmas – medium and small – appear to be embracing it.  At least, that is the case with the cross-section of companies that participated in BioSpace’s The New Hybrid Workplace: Creating Fair Policies panel on September 15. The life sciences industry is unique in that some work must inevitably be […]

Interim results from a study investigating OpRegen suggest a single treatment may provide improvements in patients with dry age-related macular degeneration with geographic atrophy, according to a Lineage Cell Therapeutics press release. OpRegen, an investigational cell therapy consisting of allogeneic retinal pigment epithelium (RPE) cells administered to the subretinal space, demonstrated positive findings in the phase […]

OpRegen, a cell therapy from Lineage Cell Therapeutics, continues to show efficacy, with demonstrated anatomical and functional improvements in geographic atrophy (GA) in dry age-related macular degeneration (AMD), according to updated interim results from its ongoing phase 1/2a clinical study (NCT02286089). Lineage announced the data in support of the investigative therapy’s efficacy, including an average difference […]